AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H194-H203, 2003; doi:10.1152/ajpheart.00971.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunner, M.
Right arrow Articles by Koren, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunner, M.
Right arrow Articles by Koren, G.

In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype

Michael Brunner,1,* Sodikdjon A. Kodirov,1,* Gary F. Mitchell,2 Peter D. Buckett,1 Katsushi Shibata,1 Eduardo J. Folco,1 Linda Baker,3 Guy Salama,3 Danny P. Chan,1 Jun Zhou,1 and Gideon Koren1

1Bioelectricity Laboratory, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston 02115; 2Cardiovascular Engineering Incorporated, Holliston, Massachusetts 01746; and 3Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261

Submitted 18 November 2002 ; accepted in final form 26 February 2003

Mutations in cardiac voltage-gated K+ channels cause long QT syndrome (LQTS) and sudden death. We created a transgenic mouse with a long QT phenotype (Kv1DN) by overexpression of a truncated K+ channel in the heart and investigated whether the dominant negative effect of the transgene would be overcome by the direct injection of adenoviral vectors expressing wild-type Kv1.5 (AV-Kv1.5) into the myocardium. End points at 3–10 days included electrophysiology in isolated cardiomyocytes, surface ECG, programmed stimulation of the right ventricle, and in vivo optical mapping of action potentials and repolarization gradients in Langendorff-perfused hearts. Overexpression of Kv1.5 reconstituted a 4-aminopyridine-sensitive outward K+ current, shortened the action potential duration, eliminated early afterdepolarizations, shortened the QT interval, decreased dispersion of repolarization, and increased the heart rate. Each of these changes is consistent with a physiologically significant primary effect of adenoviral expression of Kv1.5 on ventricular repolarization of Kv1DN mice.

adenovirus; action potentials; early afterdepolarizations



Address for reprint requests and other correspondence: G. Koren, Bioelectricity Laboratory, Cardiovascular Div., Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115 (E-mail: koren{at}calvin.bwh.harvard.edu).




This article has been cited by other articles:


Home page
J. Physiol.Home page
G. Salama and B. London
Mouse models of long QT syndrome
J. Physiol., January 1, 2007; 578(1): 43 - 53.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. R. Efimov, V. P. Nikolski, and G. Salama
Optical Imaging of the Heart
Circ. Res., July 9, 2004; 95(1): 21 - 33.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. P. Zipes
The year in electrophysiology
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1306 - 1314.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.